Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Post-COVID-19 Persistent Cough
NCT05447039Completed
- Sponsor
- Assiut University
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of montelukast in chronic cough (2 arms), sponsored by Assiut University. Primary endpoints: Cough Severity Index at 14 days and Cough Severity Visual Analog Scale at 14 days. Started Sep 2020; status: completed.
02
Drugs
montelukast
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT05447039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447039.